Cannabis Market in Mexico

Mexico has been on the verge of cannabis legalization for years, driven by a series of landmark Supreme Court rulings that declared the prohibition of personal cannabis use unconstitutional. In 2021, the Supreme Court of Justice of the Nation (SCJN) formally struck down the prohibition, establishing that adults have a constitutional right to use cannabis for recreational purposes. However, translating this judicial ruling into comprehensive legislation has proven extremely challenging, with multiple draft bills stalling in Congress due to political disagreements over market structure, social equity provisions, and regulatory oversight.

The Mexican medical cannabis framework was established in 2017 through amendments to the General Health Law, and implementing regulations were published in 2021. The Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) oversees licensing for medical cannabis products, including importation, production, and sale. However, the medical market has been slow to develop due to regulatory delays in issuing licenses, limited physician education about cannabis prescribing, and the lack of domestic production infrastructure. Most medical cannabis products available in Mexico are imported.

Mexico's potential as a cannabis market is enormous by any measure. With a population of approximately 130 million, it would become one of the largest cannabis markets globally upon full legalization. The country's agricultural capacity, climate diversity, and existing expertise in commercial agriculture position it well for large-scale cultivation. Furthermore, Mexico's geographic proximity to the United States — the world's largest cannabis market — creates natural synergies for trade, particularly if US federal legalization eventually enables cross-border cannabis commerce.

The investment landscape in Mexican cannabis is almost entirely pre-commercialization. Very few publicly traded companies focus specifically on the Mexican market, and the regulatory uncertainty makes it difficult for companies to plan long-term strategies. Some Canadian and US companies have made exploratory investments in Mexico, and several Mexican startups are positioning for the eventual market opening. The most common investment thesis centers on being early to a massive market, but the timeline for full commercial operations remains uncertain. Mexico's cannabis story is one of enormous potential waiting for regulatory clarity.